DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Adhesiveness of a new testosterone-in-adhesive matrix patch after extreme conditions.

Author(s): Raynaud JP, Auges M, Liorzou L, Turlier V, Lauze C

Affiliation(s): Universite Pierre et Marie Curie, 4 place Jussieu, 51 Bd Suchet, 75252 Paris Cedex 05, 75016 Paris, France. jeanpierre@raynaud.ws

Publication date & source: 2009-06-22, Int J Pharm., 375(1-2):28-32. Epub 2009 Apr 1.

Publication type: Randomized Controlled Trial

The objective of the study was to evaluate the adhesiveness of a new thin, transparent and comfortable testosterone-in-adhesive matrix patch, Testopatch, after extreme conditions. The study was a single-centre, open-label with randomization of sites (upper arms, lower back, thighs) and sides (left, right) of two 45 cm(2) patches, in 24 healthy subjects. Patches were symmetrically applied on one of the three sites. One patch was removed after 2.0 h, under resting conditions and the other patch was removed at 3.5 h, after extreme conditions (physical exercise, sauna, whirl bath). Adhesiveness was assessed of the area stuck and the measure of the forces necessary for patch removal using a Peel Patch Tester. Local safety was assessed at 2.0 and 3.5 h. After physical exercise and after sauna, patch adhesiveness was excellent (95%) when applied on the thigh and very good (90%) on the upper arm. Forces of patch removal were significantly lower at 3.5 h than 2.0 h, and at the lower back compared to the other application sites. There were no adverse effects. Slight erythema was observed that was considered to be clinically insignificant. Testopatch was safe and displayed adhesiveness, compatible with physical activities.

Page last updated: 2009-10-20

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017